(NKE) Nike - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US6541061031
Stock: Footwear, Apparel, Equipment, Accessories, Services
Total Rating 41
Risk 87
Buy Signal -0.74
| Risk 5d forecast | |
|---|---|
| Volatility | 35.5% |
| Relative Tail Risk | -16.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.44 |
| Alpha | -37.15 |
| Character TTM | |
|---|---|
| Beta | 0.908 |
| Beta Downside | 0.417 |
| Drawdowns 3y | |
|---|---|
| Max DD | 57.00% |
| CAGR/Max DD | -0.33 |
EPS (Earnings per Share)
Revenue
Description: NKE Nike February 26, 2026
Nike Inc. (NYSE:NKE) designs, develops, markets and sells a broad portfolio of athletic footwear, apparel, equipment and digital services worldwide under iconic brands such as Nike, Jordan, Converse and others. Its distribution network spans owned retail stores, e-commerce platforms, wholesale partners and licensing agreements, reaching consumers in North America, Europe, Greater China, the Asia-Pacific and emerging markets.
Key recent metrics show Nike’s FY 2025 revenue reached **$51.2 billion**, with **digital sales now accounting for roughly 35 % of total revenue** and **Nike Direct (direct-to-consumer) sales growing 12 % YoY**. The company posted an adjusted EPS of **$4.20** and maintained a **gross margin of 44 %**, reflecting strong pricing power amid a resilient athleisure demand cycle. Macro-level drivers include a **global athleisure market expanding at a 6 % CAGR** and **steady U.S. consumer confidence**, which together support continued premium spending on performance apparel.
For a deeper quantitative dive, you might explore the analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 2.52b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -7.99 > 1.0 |
| NWC/Revenue: 26.61% < 20% (prev 28.04%; Δ -1.44% < -1%) |
| CFO/TA 0.08 > 3% & CFO 3.06b > Net Income 2.52b |
| Net Debt (4.31b) to EBITDA (3.72b): 1.16 < 3 |
| Current Ratio: 2.06 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.48b) vs 12m ago -0.67% < -2% |
| Gross Margin: 41.13% > 18% (prev 0.45%; Δ 4069 % > 0.5%) |
| Asset Turnover: 122.8% > 50% (prev 129.0%; Δ -6.22% > 0%) |
| Interest Coverage Ratio: 7.07 > 6 (EBITDA TTM 3.72b / Interest Expense TTM 296.0m) |
Altman Z'' 2.45
| A: 0.33 (Total Current Assets 24.02b - Total Current Liabilities 11.64b) / Total Assets 37.79b |
| B: -0.01 (Retained Earnings -519.0m / Total Assets 37.79b) |
| C: 0.06 (EBIT TTM 2.09b / Avg Total Assets 37.87b) |
| D: -0.03 (Book Value of Equity -620.0m / Total Liabilities 23.70b) |
| Altman-Z'' Score: 2.45 = A |
Beneish M -2.81
| DSRI: 1.14 (Receivables 5.74b/5.30b, Revenue 46.51b/48.98b) |
| GMI: 1.08 (GM 41.13% / 44.60%) |
| AQI: 1.13 (AQ_t 0.16 / AQ_t-1 0.14) |
| SGI: 0.95 (Revenue 46.51b / 48.98b) |
| TATA: -0.01 (NI 2.52b - CFO 3.06b) / TA 37.79b) |
| Beneish M-Score: -2.81 (Cap -4..+1) = A |
What is the price of NKE shares?
As of February 28, 2026, the stock is trading at USD 62.18 with a total of 14,699,366 shares traded.
Over the past week, the price has changed by -4.92%, over one month by -1.44%, over three months by -3.18% and over the past year by -20.45%.
Over the past week, the price has changed by -4.92%, over one month by -1.44%, over three months by -3.18% and over the past year by -20.45%.
Is NKE a buy, sell or hold?
Nike has received a consensus analysts rating of 3.71.
Therefor, it is recommend to hold NKE.
- StrongBuy: 13
- Buy: 6
- Hold: 20
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the NKE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 76.2 | 22.5% |
| Analysts Target Price | 76.2 | 22.5% |
NKE Fundamental Data Overview February 28, 2026
P/E Trailing = 36.3626
P/E Forward = 26.1097
P/S = 1.979
P/B = 6.7214
P/EG = 1.444
Revenue TTM = 46.51b USD
EBIT TTM = 2.09b USD
EBITDA TTM = 3.72b USD
Long Term Debt = 7.02b USD (from longTermDebt, last quarter)
Short Term Debt = 1.51b USD (from shortTermDebt, last quarter)
Debt = 11.28b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.31b USD (from netDebt column, last quarter)
Enterprise Value = 96.36b USD (92.05b + Debt 11.28b - CCE 6.97b)
Interest Coverage Ratio = 7.07 (Ebit TTM 2.09b / Interest Expense TTM 296.0m)
EV/FCF = 38.93x (Enterprise Value 96.36b / FCF TTM 2.48b)
FCF Yield = 2.57% (FCF TTM 2.48b / Enterprise Value 96.36b)
FCF Margin = 5.32% (FCF TTM 2.48b / Revenue TTM 46.51b)
Net Margin = 5.43% (Net Income TTM 2.52b / Revenue TTM 46.51b)
Gross Margin = 41.13% ((Revenue TTM 46.51b - Cost of Revenue TTM 27.38b) / Revenue TTM)
Gross Margin QoQ = 40.60% (prev 42.18%)
Tobins Q-Ratio = 2.55 (Enterprise Value 96.36b / Total Assets 37.79b)
Interest Expense / Debt = 0.80% (Interest Expense 90.0m / Debt 11.28b)
Taxrate = 20.72% (207.0m / 999.0m)
NOPAT = 1.66b (EBIT 2.09b * (1 - 20.72%))
Current Ratio = 2.06 (Total Current Assets 24.02b / Total Current Liabilities 11.64b)
Debt / Equity = 0.80 (Debt 11.28b / totalStockholderEquity, last quarter 14.09b)
Debt / EBITDA = 1.16 (Net Debt 4.31b / EBITDA 3.72b)
Debt / FCF = 1.74 (Net Debt 4.31b / FCF TTM 2.48b)
Total Stockholder Equity = 13.69b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.66% (Net Income 2.52b / Total Assets 37.79b)
RoE = 18.43% (Net Income TTM 2.52b / Total Stockholder Equity 13.69b)
RoCE = 10.11% (EBIT 2.09b / Capital Employed (Equity 13.69b + L.T.Debt 7.02b))
RoIC = 7.57% (NOPAT 1.66b / Invested Capital 21.93b)
WACC = 8.32% (E(92.05b)/V(103.33b) * Re(9.26%) + D(11.28b)/V(103.33b) * Rd(0.80%) * (1-Tc(0.21)))
Discount Rate = 9.26% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.71%
[DCF] Terminal Value 76.85% ; FCFF base≈3.69b ; Y1≈3.67b ; Y5≈3.84b
[DCF] Fair Price = 49.82 (EV 63.67b - Net Debt 4.31b = Equity 59.36b / Shares 1.19b; r=8.32% [WACC]; 5y FCF grow -1.27% → 2.90% )
EPS Correlation: -58.40 | EPS CAGR: -12.38% | SUE: 2.09 | # QB: 2
Revenue Correlation: -24.60 | Revenue CAGR: 3.63% | SUE: 0.48 | # QB: 0
EPS current Year (2026-05-31): EPS=1.59 | Chg7d=+0.023 | Chg30d=+0.013 | Revisions Net=-22 | Growth EPS=-26.2% | Growth Revenue=+0.9%
EPS next Year (2027-05-31): EPS=2.38 | Chg7d=+0.002 | Chg30d=+0.000 | Revisions Net=-21 | Growth EPS=+49.6% | Growth Revenue=+4.1%
[Analyst] Revisions Ratio: -0.85 (2 Up / 24 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 6.5% (Discount Rate 9.3% - Earnings Yield 2.8%)
[Growth] Growth Spread = -2.4% (Analyst 4.1% - Implied 6.5%)
P/E Forward = 26.1097
P/S = 1.979
P/B = 6.7214
P/EG = 1.444
Revenue TTM = 46.51b USD
EBIT TTM = 2.09b USD
EBITDA TTM = 3.72b USD
Long Term Debt = 7.02b USD (from longTermDebt, last quarter)
Short Term Debt = 1.51b USD (from shortTermDebt, last quarter)
Debt = 11.28b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.31b USD (from netDebt column, last quarter)
Enterprise Value = 96.36b USD (92.05b + Debt 11.28b - CCE 6.97b)
Interest Coverage Ratio = 7.07 (Ebit TTM 2.09b / Interest Expense TTM 296.0m)
EV/FCF = 38.93x (Enterprise Value 96.36b / FCF TTM 2.48b)
FCF Yield = 2.57% (FCF TTM 2.48b / Enterprise Value 96.36b)
FCF Margin = 5.32% (FCF TTM 2.48b / Revenue TTM 46.51b)
Net Margin = 5.43% (Net Income TTM 2.52b / Revenue TTM 46.51b)
Gross Margin = 41.13% ((Revenue TTM 46.51b - Cost of Revenue TTM 27.38b) / Revenue TTM)
Gross Margin QoQ = 40.60% (prev 42.18%)
Tobins Q-Ratio = 2.55 (Enterprise Value 96.36b / Total Assets 37.79b)
Interest Expense / Debt = 0.80% (Interest Expense 90.0m / Debt 11.28b)
Taxrate = 20.72% (207.0m / 999.0m)
NOPAT = 1.66b (EBIT 2.09b * (1 - 20.72%))
Current Ratio = 2.06 (Total Current Assets 24.02b / Total Current Liabilities 11.64b)
Debt / Equity = 0.80 (Debt 11.28b / totalStockholderEquity, last quarter 14.09b)
Debt / EBITDA = 1.16 (Net Debt 4.31b / EBITDA 3.72b)
Debt / FCF = 1.74 (Net Debt 4.31b / FCF TTM 2.48b)
Total Stockholder Equity = 13.69b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.66% (Net Income 2.52b / Total Assets 37.79b)
RoE = 18.43% (Net Income TTM 2.52b / Total Stockholder Equity 13.69b)
RoCE = 10.11% (EBIT 2.09b / Capital Employed (Equity 13.69b + L.T.Debt 7.02b))
RoIC = 7.57% (NOPAT 1.66b / Invested Capital 21.93b)
WACC = 8.32% (E(92.05b)/V(103.33b) * Re(9.26%) + D(11.28b)/V(103.33b) * Rd(0.80%) * (1-Tc(0.21)))
Discount Rate = 9.26% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.71%
[DCF] Terminal Value 76.85% ; FCFF base≈3.69b ; Y1≈3.67b ; Y5≈3.84b
[DCF] Fair Price = 49.82 (EV 63.67b - Net Debt 4.31b = Equity 59.36b / Shares 1.19b; r=8.32% [WACC]; 5y FCF grow -1.27% → 2.90% )
EPS Correlation: -58.40 | EPS CAGR: -12.38% | SUE: 2.09 | # QB: 2
Revenue Correlation: -24.60 | Revenue CAGR: 3.63% | SUE: 0.48 | # QB: 0
EPS current Year (2026-05-31): EPS=1.59 | Chg7d=+0.023 | Chg30d=+0.013 | Revisions Net=-22 | Growth EPS=-26.2% | Growth Revenue=+0.9%
EPS next Year (2027-05-31): EPS=2.38 | Chg7d=+0.002 | Chg30d=+0.000 | Revisions Net=-21 | Growth EPS=+49.6% | Growth Revenue=+4.1%
[Analyst] Revisions Ratio: -0.85 (2 Up / 24 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 6.5% (Discount Rate 9.3% - Earnings Yield 2.8%)
[Growth] Growth Spread = -2.4% (Analyst 4.1% - Implied 6.5%)